Danny Talati

Danny is the Lead of Business Development at ATAI Life Sciences; he primarily focuses on sourcing new investment opportunities in the mental health space.  Danny has spent 15+ years in neuroscience and is passionate about identifying innovative therapies with the potential to impact the treatment of mental health disorders.